ici 204,219 has been researched along with Cystic Fibrosis in 2 studies
zafirlukast: a leukotriene D4 receptor antagonist
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conway, SP | 1 |
| Etherington, C | 1 |
| Peckham, DG | 1 |
| Whitehead, A | 1 |
| Santais, MC | 1 |
| Callens, E | 1 |
| Djebbar, R | 1 |
| Ruff, F | 1 |
1 review available for ici 204,219 and Cystic Fibrosis
| Article | Year |
|---|---|
[Potential importance of antileukotrienes in the treatment of asthma and other inflammatory diseases: apropos of a new pharmacological class].
Topics: Acetophenones; Adult; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthr | 1998 |
1 trial available for ici 204,219 and Cystic Fibrosis
| Article | Year |
|---|---|
A pilot study of zafirlukast as an anti-inflammatory agent in the treatment of adults with cystic fibrosis.
Topics: Adult; Anti-Inflammatory Agents; Cystic Fibrosis; Female; Humans; Indoles; Leukotriene Antagonists; | 2003 |